4 completed, 2 terminated, 1 unknown. 4 Phase 4, 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 2, Completed 1, Unknown 1 |
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Drug Tapering: new trials by email Literature Review of Drug Tapering trials Research Report on Drug Tapering
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact in Older Adults of Reducing Anticholinergic and Sedative Rx Burden on Physical Function Measured by Wearables Deprescribing anticholinergic and sedative mediications - Deprescribing Anticholinergic and Sedative Medications, Physical Function | Phase 4 | Unknown | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 182 | 2023-03-23 | 2023-09-18 |
| Dose Tapering Study of Adalimumab in Psoriasis Venapuncture, Dried blood spot, Dose reduction - Psoriasis Vulgaris | Phase 4 | Terminated | University Hospital, Ghent | 19 | 2021-02-16 | 2024-09-19 |
| Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up Tapering - Chronic Pain, Analgesics, Opioid | Not applicable | Completed | Lund University Hospital | 140 | 2018-03-22 | 2026-04-20 |
| A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate Dosage Methotrexate (stable dose), Tocilizumab, Methotrexate (tapering dose) - Rheumatoid Arthritis | Phase 4 | Terminated | Hoffmann-La Roche | 427 | 2012-09-01 | 2016-10-14 |
| Lenalidomide (Revlimid®) Plus Low-dose Dexamethasone (Ld x 4 Cycles) Then Stem Cell Collection Followed by Randomization to Continued Ld or Stem Cell Transplantation (SCT) Plus Maintenance L Stem cell transplant x 1 or x 2, lenalidomide and dexamethasone - Multiple Myeloma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 67 | 2008-12-10 | 2019-03-15 |
| Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours tipranavir/ritonavir (dose reduction) - HIV Infections | Phase 4 | Completed | Germans Trias i Pujol Hospital | 11 | 2007-12-01 | 2019-12-05 |
| Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral Therapy switching; dose reduction - HIV Infections, Lipoatrophy | Not applicable | Completed | Hospital Clinic of Barcelona | 60 | 2004-01-01 | 2006-10-24 |
HIV Infections (2) · Acquired Immunodeficiency Syndrome (1) · Arthritis, Rheumatoid (1) · Chronic Pain (1) · Lipodystrophy (1) · Multiple Myeloma (1) · Psoriasis (1) · Substance-Related Disorders (1)
Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1) · Germans Trias i Pujol Hospital (1) · Hoffmann-La Roche (1) · Hospital Clinic of Barcelona (1) · Lund University Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · University Hospital, Ghent (1)
Belgium (1) · Canada (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
Hani Hassoun, MD (1) · Jo Lambert, Prof, dr (1) · Jose Maria Gatell (1) · Molto Jose, MD,PhD (1)